SPARTA Biodiscovery Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.73M
- Investors
-
4
SPARTA Biodiscovery General Information
Description
Provider of nanoparticle analytical testing services catering to the pharmaceutical and biotechnology industry. The company offers analytical testing of nanoparticle types used for diagnostic and therapeutic purposes, enabling clients to get simultaneous size and chemical compositional analysis on a single-particle basis.
Contact Information
Website
www.spartabiodiscovery.comCorporate Office
- Scale Space White City
- 58 Wood Lane
- London W12 7RZ
- England, United Kingdom
Corporate Office
- Scale Space White City
- 58 Wood Lane
- London W12 7RZ
- England, United Kingdom
SPARTA Biodiscovery Timeline
SPARTA Biodiscovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 09-Apr-2026 | $1.73M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 16-Jul-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2022 | Completed | Generating Revenue |
SPARTA Biodiscovery Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 36,269 | $0.000133 | $64.19 | $64.19 | 1x | $64.19 | 18.07% | |
| Ordinary | 5,484 | $0.000133 | $54.54 | $54.54 | 1x | $54.54 | 2.73% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SPARTA Biodiscovery Patents
SPARTA Biodiscovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026132118-A2 | Non-contact raman spectroscopy system and methods for using the same | Pending | 17-Dec-2024 | ||
| WO-2026132118-A3 | Non-contact raman spectroscopy system and methods for using the same | Pending | 17-Dec-2024 | ||
| US-12455224-B2 | Single particle automated raman trapping analysis | Active | 19-Jun-2018 | G01N15/1434 |
SPARTA Biodiscovery Signals
SPARTA Biodiscovery Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Providence Investment Company | Venture Capital | Minority | ||
| Sartorius | Corporation | Minority | ||
| Imperial College London | University | |||
| Imperial Enterprise Lab | Accelerator/Incubator |
SPARTA Biodiscovery FAQs
-
When was SPARTA Biodiscovery founded?
SPARTA Biodiscovery was founded in 2022.
-
Where is SPARTA Biodiscovery headquartered?
SPARTA Biodiscovery is headquartered in London, United Kingdom.
-
What is the size of SPARTA Biodiscovery?
SPARTA Biodiscovery has 12 total employees.
-
What industry is SPARTA Biodiscovery in?
SPARTA Biodiscovery’s primary industry is Discovery Tools (Healthcare).
-
Is SPARTA Biodiscovery a private or public company?
SPARTA Biodiscovery is a Private company.
-
What is the current valuation of SPARTA Biodiscovery?
The current valuation of SPARTA Biodiscovery is .
-
What is SPARTA Biodiscovery’s current revenue?
The current revenue for SPARTA Biodiscovery is .
-
How much funding has SPARTA Biodiscovery raised over time?
SPARTA Biodiscovery has raised $6.79M.
-
Who are SPARTA Biodiscovery’s investors?
Providence Investment Company, Sartorius, Imperial College London, and Imperial Enterprise Lab have invested in SPARTA Biodiscovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process